MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical Devices Regulatory Reform – Roadmap to implementation – Update

A roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices and an intended policy on international recognition...

Europe – MDCG 2024-16: Manufacturer Information Form on Interruption or Discontinuation of Supply of...

The Medical Device Coordination Group (MDCG) has introduced new guidance under MDCG 2024-16, streamlining how manufacturers report interruptions or discontinuations in the supply of...

Europe – MDCG 2024-15 – Guidance on the publication of the clinical investigation reports...

Article 77(5) MDR requires that the sponsor submits to the Member States in which a clinical investigation was conducted a clinical investigation report within...
TEAM-NB : Survey on NBs applications against IVD new regulation

Europe – Medical devices AI questionnaire IG-NB & Team NB

This questionnaire is jointly published by the German Notified Bodies Alliance for Medical Devices (Interessengemeinschaft der Benannten Stellen für Medizinprodukte in Deutschland - IGNB)...

Europe – MDCG 2024-14 – Guidance on the implementation of the Master UDI-DI solution...

The introduction of the Unique Device Identification (UDI) system referred to in Article 27 of Regulation (EU) 2017/745 on medical devices (MDR) aims to...

Europe – Gradual roll out of EUDAMED – Q&As on practical aspects related to...

The amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 addresses three topics: 1. Regulation (EU) 2024/1860 aims to ensure a high...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical Devices Regulations: Routes to market and in vitro diagnostic devices

This consultation applies to medical devices in Great Britain. For guidance on the regulation of devices in Northern Ireland, see Regulation of devices in Northern...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2023-3 Rev. 1 Questions and Answers on vigilance terms and concepts...

This document aims to clarify important terms and concepts that are outlined in Section 2 of Chapter VII of Regulation (EU) 2017/745 on medical...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Experts: Notified body survey shows MDR/IVDR progress despite some snags

A recent survey shows progress in the number of applications being filed with notified bodies (NB) and certificates issued under the EU Medical Device...

Europe – Q&A Obligation to inform in case of interruption or discontinuation of supply

Introduction – Objectives of the MDR/IVDR amendment The amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 addresses three topics: 1. Regulation (EU)...

NOS PROCHAINES FORMATIONS